Eton Pharmaceuticals (ETON) Return on Capital Employed Growth (5y) (2023 - 2025)
Eton Pharmaceuticals (ETON) Return on Capital Employed Growth (5y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Eton Pharmaceuticals | 1.15 Bn | 1.13 Bn | 13.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,857.00 |
| Sep 30, 2025 | 22,446.00 |
| Jun 30, 2025 | 15,896.00 |
| Mar 31, 2025 | 12,778.00 |
| Dec 31, 2024 | 13,237.00 |
| Sep 30, 2024 | 8,643.00 |
| Jun 30, 2024 | 3,324.00 |
| Mar 31, 2024 | 7,112.00 |
| Dec 31, 2023 | 5,716.00 |